New Article on Disease Modifying Data with NeuroRestore ACD856 against Alzheimer’s now Available Online

AlzeCure Pharma AB announced that a new scientific article on preclinical results supporting a disease-modifying effect with NeuroRestore ACD856 has been made available online.